ImmunoGen, Inc.
IMGNDelisted Feb 12, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000855654
ImmunoGen, Inc. was delisted on Feb 12, 2024; its insiders filed their last Form 4 on Feb 12, 2024; 327 institutions reported holding it in 13F filings for Q4 2023, worth $7.54B in total; Maverick Capital was the only superinvestor holding it.
Q1 2023 vs. Q4 2022
How the institutions holding ImmunoGen, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Of which not filed for Q1 2023 | Q1 2023 | Change |
|---|---|---|---|---|
| Holders | 204 | 4 | 191 | −9 |
| Shares | 204.0M | 163.9K | 210.0M | +6.17M (+3.0%) |
| Value | $1.01B | $806.8K | $806.0M | −$204.8M (−20.3%) |
4 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (21)
Institutions that held ImmunoGen, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Artisan Partners Limited Partnership | 3,181,379 | $12.2M | 0.02% |
| Profund Advisors LLC | 252,826 | $970.9K | 0.06% |
| Ghost Tree Capital, LLC | 124,977 | $480.0K | 0.18% |
| Renaissance Technologies LLC | 79,140 | $304.0K | 0.00% |
| Apollon Wealth Management, LLC | 50,000 | $192.0K | 0.01% |
| Aquatic Capital Management LLC | 49,000 | $188.0K | 0.01% |
| SEI Investments Co | 45,121 | $173.3K | 0.00% |
| Qube Research & Technologies Ltd | 42,516 | $163.3K | 0.00% |
| AXA S.A. | 32,900 | $126.3K | 0.00% |
| BIT Capital GmbH | 32,130 | $123.4K | 0.02% |
| ExodusPoint Capital Management, LP | 31,268 | $120.0K | 0.00% |
| Gsa Capital Partners LLP | 29,800 | $114.0K | 0.01% |
| BFT Financial Group, LLC | 25,000 | $96.0K | 0.01% |
| CM Wealth Advisors LLC | 18,934 | $80.0K | 0.02% |
| PEAK6 Investments LLC | 20,000 | $76.8K | 0.00% |
| Lazard Asset Management LLC | 15,232 | $58.0K | 0.00% |
| Belvedere Trading LLC | 10,034 | $38.5K | 0.02% |
| TD Capital Management LLC | 3,000 | $11.5K | 0.00% |
| Dark Forest Capital Management LP | 419 | $1.61K | 0.00% |
| Allworth Financial LP | 300 | $1.15K | 0.00% |
| Parallel Advisors, LLC | 98 | $376 | 0.00% |
Sold out (30)
Institutions that held ImmunoGen, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
Not filed for Q1 2023 yet (4)
Institutions that held ImmunoGen, Inc. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| HealthCor Management, L.P. | 150,000 | $744.0K |
| Comerica Bank | 12,500 | $56.0K |
| HealthInvest Partners AB | 1,300 | $6.45K |
| CoreCap Advisors, LLC | 67 | $332 |